tiprankstipranks
MannKind reports six-month results from Phase 3 INHALE-1 trial
PremiumThe FlyMannKind reports six-month results from Phase 3 INHALE-1 trial
1M ago
MannKind, Cipla: CDSCO in India approves Afrezza Inhalation Powder in India
Premium
The Fly
MannKind, Cipla: CDSCO in India approves Afrezza Inhalation Powder in India
1M ago
Leerink healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Leerink healthcare analysts hold an analyst/industry conference call
2M ago
MannKind reports results from Phase 1 study of nintedanib DPI
PremiumThe FlyMannKind reports results from Phase 1 study of nintedanib DPI
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
MannKind announces 30-week results from Phase 4 INHALE-3 study
Premium
The Fly
MannKind announces 30-week results from Phase 4 INHALE-3 study
4M ago
MannKind Announces Board of Directors Transition
PremiumCompany AnnouncementsMannKind Announces Board of Directors Transition
5M ago
MannKind director Kent Kresa to retire from board
Premium
The Fly
MannKind director Kent Kresa to retire from board
5M ago
MannKind reports Q2 adjusted EPS 5c, consensus 1c
Premium
The Fly
MannKind reports Q2 adjusted EPS 5c, consensus 1c
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100